US Patent 9120855 Biologic compounds directed against death receptor 5
Patent 9120855 was granted and assigned to Novartis on September, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 9, 2011
0
Date of Patent
September 1, 2015
0
Patent Application Number
13024174
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9120855 Biologic compounds directed against death receptor 5
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
